New study may help predict cardiometabolic disease risk and personalize prevention strategies
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Jul-2025 08:10 ET (26-Jul-2025 12:10 GMT/UTC)
A new study explores how epigenetic markers—chemical modifications that influence gene activity—can help predict the risk of developing cardiometabolic diseases and guide personalized prevention strategies. The findings are particularly significant as the prevalence of major cardiometabolic risk factors such as hypertension, diabetes, and obesity continues to rise despite advancements in healthcare and treatment. This trend highlights the need for better early detection and intervention.
Five days after the attack: 41% of participants reported peritraumatic distress and 19% reported experiencing anxiety
A new study indicates high levels of emotional distress and anxiety in the days following the Iranian drone and missile attack on Israel on April 13, 2024. The study was conducted by Prof. Boaz Ben-David, Dr. Ortal Shimon-Raz, and Tchelet Bressler from the Baruch Ivcher School of Psychology at Reichman University, Dr. Lia Ring from Ashkelon College, and Prof. Yuval Palgi from the University of Haifa. The study, which was based on a sample of over 600 adults, presents a concerning picture of the immediate emotional consequences of the attack.
Researchers have shed new light on how tissues in the body are repaired following the damage and premature death of tissue cells.
The pathogen C. diff — the most common cause of health care-associated infectious diarrhea — can use a compound that kills the human gut’s resident microbes to survive and grow, giving it a competitive advantage in the infected gut.
A team led by investigators at Vanderbilt University Medical Center has discovered how C. diff (Clostridioides difficile) converts the poisonous compound 4-thiouracil, which could come from foods like broccoli, into a usable nutrient. Their findings, published March 25 in the journal Cell Host & Microbe, increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies.